BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19729012)

  • 1. Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations.
    Gu BW; Zhao C; Fan JM; Dai Q; Bessler M; Mason PJ
    FEBS Lett; 2009 Sep; 583(18):3086-90. PubMed ID: 19729012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
    Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
    Machado-Pinilla R; Carrillo J; Manguan-Garcia C; Sastre L; Mentzer A; Gu BW; Mason PJ; Perona R
    Clin Transl Oncol; 2012 Oct; 14(10):755-63. PubMed ID: 22855157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
    Garus A; Autexier C
    RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
    Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
    Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudouridylation defect due to
    Balogh E; Chandler JC; Varga M; Tahoun M; Menyhárd DK; Schay G; Goncalves T; Hamar R; Légrádi R; Szekeres Á; Gribouval O; Kleta R; Stanescu H; Bockenhauer D; Kerti A; Williams H; Kinsler V; Di WL; Curtis D; Kolatsi-Joannou M; Hammid H; Szőcs A; Perczel K; Maka E; Toldi G; Sava F; Arrondel C; Kardos M; Fintha A; Hossain A; D'Arco F; Kaliakatsos M; Koeglmeier J; Mifsud W; Moosajee M; Faro A; Jávorszky E; Rudas G; Saied MH; Marzouk S; Kelen K; Götze J; Reusz G; Tulassay T; Dragon F; Mollet G; Motameny S; Thiele H; Dorval G; Nürnberg P; Perczel A; Szabó AJ; Long DA; Tomita K; Antignac C; Waters AM; Tory K
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15137-15147. PubMed ID: 32554502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
    Bellodi C; Krasnykh O; Haynes N; Theodoropoulou M; Peng G; Montanaro L; Ruggero D
    Cancer Res; 2010 Jul; 70(14):6026-35. PubMed ID: 20587522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow growth and unstable ribosomal RNA lacking pseudouridine in mouse embryonic fibroblast cells expressing catalytically inactive dyskerin.
    Gu BW; Ge J; Fan JM; Bessler M; Mason PJ
    FEBS Lett; 2013 Jul; 587(14):2112-7. PubMed ID: 23726835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA.
    Schwartz S; Bernstein DA; Mumbach MR; Jovanovic M; Herbst RH; León-Ricardo BX; Engreitz JM; Guttman M; Satija R; Lander ES; Fink G; Regev A
    Cell; 2014 Sep; 159(1):148-162. PubMed ID: 25219674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.
    Yoon A; Peng G; Brandenburger Y; Zollo O; Xu W; Rego E; Ruggero D
    Science; 2006 May; 312(5775):902-6. PubMed ID: 16690864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice.
    Gu BW; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10173-8. PubMed ID: 18626023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskerin ablation in mouse liver inhibits rRNA processing and cell division.
    Ge J; Rudnick DA; He J; Crimmins DL; Ladenson JH; Bessler M; Mason PJ
    Mol Cell Biol; 2010 Jan; 30(2):413-22. PubMed ID: 19917719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
    Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
    Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita.
    Rashid R; Liang B; Baker DL; Youssef OA; He Y; Phipps K; Terns RM; Terns MP; Li H
    Mol Cell; 2006 Jan; 21(2):249-60. PubMed ID: 16427014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskeratosis congenita: a disorder of defective telomere maintenance?
    Walne AJ; Marrone A; Dokal I
    Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.
    Montanaro L
    J Pathol; 2010 Dec; 222(4):345-9. PubMed ID: 20925138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.